Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
beatrice.musumeci@uniroma1.it
Maria Beatrice Musumeci
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
E-mail:
beatrice.musumeci@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes
INTERNATIONAL JOURNAL OF CARDIOLOGY
2024
Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Incident Cancer
HEART LUNG & CIRCULATION
2024
Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE
2024
Neurological Disorders in Takotsubo Syndrome: Clinical Phenotypes and Outcomes
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE
2024
Statin therapy and outcome in Takotsubo syndrome patients: Results from the multicenter international GEIST registry
ATHEROSCLEROSIS
2024
Advanced Cardiovascular Magnetic Resonance Imaging in Takotsubo Syndrome: Update on Feature Tracking and Tissue Mapping
CURRENT CARDIOVASCULAR IMAGING REPORTS
2024
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis
EUROPEAN JOURNAL OF HEART FAILURE
2024
Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based Analysis
JACC. ADVANCES
2024
Re-analysis of Next-generation Sequencing Data in Patients with Hypertrophic Cardiomyopathy: Contribution of Spliceogenic MYBPC3 Variants in an Italian Cohort
ANNALS OF LABORATORY MEDICINE
2024
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study
ESC HEART FAILURE
2024
Impact of the Noninvasive Diagnostic Algorithm on Clinical Presentation and Prognosis in Cardiac Amyloidosis
JACC. ADVANCES
2024
Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies
CURRENT HEART FAILURE REPORTS
2023
A Novel Nonsense Pathogenic TTN Variant Identified in a Patient with Severe Dilated Cardiomyopathy
CURRENT ISSUES IN MOLECULAR BIOLOGY
2023
Risk stratification in transthyretin-related cardiac amyloidosis
FRONTIERS IN CARDIOVASCULAR MEDICINE
2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study
EUROPEAN JOURNAL OF HEART FAILURE
2023
Diagnostic Delay in Arrhythmogenic Cardiomyopathy
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
2023
Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy
EUROPEAN HEART JOURNAL SUPPLEMENTS
2023
Long QTc in hypertrophic cardiomyopathy: A consequence of structural myocardial damage or a distinct genetic disease?
FRONTIERS IN CARDIOVASCULAR MEDICINE
2023
Cardiovascular risk and the COVID-19 pandemic: A retrospective observational study in a population of healthcare professionals
NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
2023
[Rationale and significance of the Italian Network for Cardiac Amyloidosis]
GIORNALE ITALIANO DI CARDIOLOGIA
2023
1
2
3
4
5
6
7
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma